Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Multimodal Imaging-defined Subregions in Newly-diagnosed Glioblastoma: Impact on Overall Survival.

John F, Bosnyák E, Robinette NL, Amit-Yousif AJ, Barger GR, Shah KD, Michelhaugh SK, Klinger NV, Mittal S, Juhász C.

Neuro Oncol. 2018 Oct 22. doi: 10.1093/neuonc/noy169. [Epub ahead of print]

PMID:
30346623
2.

Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.

Guastella AR, Michelhaugh SK, Klinger NV, Fadel HA, Kiousis S, Ali-Fehmi R, Kupsky WJ, Juhász C, Mittal S.

J Neurooncol. 2018 Sep;139(2):239-249. doi: 10.1007/s11060-018-2869-6. Epub 2018 Apr 17.

PMID:
29667084
3.

Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma.

Bosnyák E, Barger GR, Michelhaugh SK, Robinette NL, Amit-Yousif A, Mittal S, Juhász C.

Clin Nucl Med. 2018 Mar;43(3):176-179. doi: 10.1097/RLU.0000000000001942.

PMID:
29261637
4.

GNAQ Mutation in the Venous Vascular Malformation and Underlying Brain Tissue in Sturge-Weber Syndrome.

Sundaram SK, Michelhaugh SK, Klinger NV, Kupsky WJ, Sood S, Chugani HT, Mittal S, Juhász C.

Neuropediatrics. 2017 Oct;48(5):385-389. doi: 10.1055/s-0037-1603515. Epub 2017 Jun 1. No abstract available.

5.

Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhász C.

J Neurosurg. 2018 Feb;128(2):414-421. doi: 10.3171/2016.9.JNS16452. Epub 2017 Feb 24.

PMID:
28298023
6.

Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.

Bosnyák E, Michelhaugh SK, Klinger NV, Kamson DO, Barger GR, Mittal S, Juhász C.

Clin Nucl Med. 2017 May;42(5):341-347. doi: 10.1097/RLU.0000000000001577.

7.

Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.

Michelhaugh SK, Muzik O, Guastella AR, Klinger NV, Polin LA, Cai H, Xin Y, Mangner TJ, Zhang S, Juhász C, Mittal S.

J Nucl Med. 2017 Feb;58(2):208-213. doi: 10.2967/jnumed.116.179994. Epub 2016 Oct 20.

8.

Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma.

Guastella AR, Michelhaugh SK, Klinger NV, Kupsky WJ, Polin LA, Muzik O, Juhász C, Mittal S.

Mol Imaging. 2016 May 5;15. pii: 1536012116644881. doi: 10.1177/1536012116644881. Print 2016.

9.

Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal.

Parajuli P, Anand R, Mandalaparty C, Suryadevara R, Sriranga PU, Michelhaugh SK, Cazacu S, Finniss S, Thakur A, Lum LG, Schalk D, Brodie C, Mittal S.

Oncotarget. 2016 Feb 2;7(5):6121-35. doi: 10.18632/oncotarget.6847.

10.

Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma.

Furgason JM, Koncar RF, Michelhaugh SK, Sarkar FH, Mittal S, Sloan AE, Barnholtz-Sloan JS, Bahassi el M.

Oncoscience. 2015 Jul 31;2(7):618-28. eCollection 2015.

11.

Acute or chronic use of lacosamide does not alter its distribution between serum and cerebrospinal fluid.

Michelhaugh SK, Basha M, Rhoney DH, Shah AK, Mittal S.

Epilepsia. 2015 Nov;56(11):1732-7. doi: 10.1111/epi.13111. Epub 2015 Aug 7.

12.

Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.

Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, Sethi S, Aboukameel A, Kiousis S, Zitron IM, Ebrahim SA, Polin LA, Sarkar FH, Bollig-Fischer A, Mittal S.

J Transl Med. 2015 Jul 15;13:227. doi: 10.1186/s12967-015-0596-8.

13.

Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.

Bosnyák E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ, Muzik O, Michelhaugh SK, Mittal S, Juhász C.

Neuro Oncol. 2015 Sep;17(9):1284-92. doi: 10.1093/neuonc/nov098. Epub 2015 Jun 18.

14.

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.

Bollig-Fischer A, Michelhaugh SK, Wijesinghe P, Dyson G, Kruger A, Palanisamy N, Choi L, Alosh B, Ali-Fehmi R, Mittal S.

Oncotarget. 2015 Jun 10;6(16):14614-24.

15.

Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.

Juhász C, Dwivedi S, Kamson DO, Michelhaugh SK, Mittal S.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00015. Review.

16.

A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype.

Bannon MJ, Johnson MM, Michelhaugh SK, Hartley ZJ, Halter SD, David JA, Kapatos G, Schmidt CJ.

Neuropsychopharmacology. 2014 Aug;39(9):2191-9. doi: 10.1038/npp.2014.70. Epub 2014 Mar 19.

17.

Towards a Targeted Molecular Approach for Brain Metastases.

Michelhaugh SK, Mittal S.

J Spine Neurosurg. 2013 Aug 10;Suppl 1. pii: S1-e002. No abstract available.

18.

Authors' response.

Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ.

J Forensic Sci. 2013 Mar;58(2):562. doi: 10.1111/1556-4029.12080. No abstract available.

19.

Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium.

Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ.

J Forensic Sci. 2012 Nov;57(6):1519-23. doi: 10.1111/j.1556-4029.2012.02212.x. Epub 2012 Jul 16.

20.

The Transcription Factor NURR1 Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes.

Johnson MM, Michelhaugh SK, Bouhamdan M, Schmidt CJ, Bannon MJ.

Front Neurosci. 2011 Dec 20;5:135. doi: 10.3389/fnins.2011.00135. eCollection 2011.

Supplemental Content

Loading ...
Support Center